
"NYC Health + Hospitals announced that three of its acute care hospitals have been named as recipients of the Level 2 Special Pathogen Treatment and Network Development (STAND) Award from the National Special Pathogen System (NSPS) on Thursday, Jan. 15. The three locations to earn this award were NYC Health + Hospitals/Elmhurst in Queens, NYC Health + Hospitals/Jacobi in the Bronx and NYC Health + Hospitals/Harlem in Manhattan."
"Receiving this designation formally recognizes these facilities as NSPS Level 2 Special Pathogen Treatment Centers (SPTCs), expanding the public health care system's capacity to safely care for patients with high-consequence infectious diseases. The awardees also each received up to $500,000 to support enhanced training, workforce readiness, infrastructure and operational planning for special pathogens. For generations, NYC Health + Hospitals has been on the frontlines of every major infectious disease threat facing our city, including the COVID-19 pandemic,"
"From early detection to specialized treatment and systemwide response, we are building the capacity New Yorkers rely on in moments of uncertainty. These designations continue our proud legacy of infectious disease response and affirm our commitment by supporting our workforce and leading with readiness when it matters most. I am thankful for our doctors, nurses, hospital staff, epidemiologists and city emergency workers who never hesitate to leap into action to support New Yorkers in their greatest time of need."
NYC Health + Hospitals/Elmhurst, NYC Health + Hospitals/Jacobi and NYC Health + Hospitals/Harlem received NSPS Level 2 Special Pathogen Treatment Center designations. Each facility was awarded up to $500,000 to support enhanced training, workforce readiness, infrastructure improvements and operational planning for special pathogens. The designations expand public health system capacity to safely care for patients with high‑consequence infectious diseases. NYC Health + Hospitals maintains a legacy of frontline infectious disease response, including COVID‑19, and focuses on early detection, specialized treatment and systemwide response. The STAND Award advances Level 2 capabilities and strengthens national readiness amid interconnected global infectious disease risks.
Read at www.amny.com
Unable to calculate read time
Collection
[
|
...
]